Bio-Connect

CYP7A1 Polyclonal Antibody

BS-2399R
Bioss
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetCYP7A1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bioss
  • Product Name
    CYP7A1 Polyclonal Antibody
  • Delivery Days Customer
    16
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    WB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 ug/ul
  • Conjugate
    Unconjugated
  • Gene ID1581
  • Target name
    CYP7A1
  • Target description
    cytochrome P450 family 7 subfamily A member 1
  • Target synonyms
    CP7A, CYP7, CYPVII, cytochrome P450 7A1, 24-hydroxycholesterol 7-alpha-hydroxylase, cholesterol 7-alpha-hydroxylase, cholesterol 7-alpha-monooxygenase, cholesterol 7alpha-hydroxylase, cytochrome P450, family 7, subfamily A, polypeptide 1, cytochrome P450, subfamily VIIA polypeptide 1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP22680
  • Protein Name
    Cytochrome P450 7A1
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Wang N, Yang B, Zhang J, et al. Metabolite profiling of traditional Chinese medicine XIAOPI formula: An integrated strategy based on UPLC-Q-Orbitrap MS combined with network pharmacology analysis. Biomed Pharmacother. 2020,121:109569. doi: 10.1016/j.biopha.2019.109569
    Read this paper
  • Zhang LY , Ding L , Shi HH , et al. Eicosapentaenoic acid in the form of phospholipids exerts superior anti-atherosclerosis effects to its triglyceride form in ApoE(-/-) mice. Food Funct. 2019,10(7):4177-4188. doi: 10.1039/c9fo00868c
    Read this paper
  • Shen X, Chen Y, Zhang J, et al. Low-dose PCB126 compromises circadian rhythms associated with disordered glucose and lipid metabolism in mice. Environ Int. 2019,128:146-157. doi: 10.1016/j.envint.2019.04.058
    Read this paper
  • Zhong D, Xie Z, Huang B, et al. Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF. Cell Physiol Biochem. 2018,49(3):1163-1179. doi: 10.1159/000493297
    Read this paper
  • Zhang JM, Wang XH, Hao LH, et al. Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cells. Environ Toxicol Pharmacol. 2017,52:21-26. doi: 10.1016/j.etap.2017.03.003
    Read this paper
  • Ma Z, Chu L, Liu H, et al. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep. 2017,7:44819. doi: 10.1038/srep44819
    Read this paper
  • Guo HL, Hassan HM, Zhang Y, et al. Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport. Toxicol Sci. 2016,152(2):417-28. doi: 10.1093/toxsci/kfw098
    Read this paper
  • Nukaya D, Minami K, Hoshikawa R, et al. Preferential gene expression and epigenetic memory of induced pluripotent stem cells derived from mouse pancreas. Genes Cells. 2015,20(5):367-81. doi: 10.1111/gtc.12227
    Read this paper
  • Gabbi C, Bertolotti M, Anzivino C, et al. Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease. Dig Liver Dis. 2012,44(12):1018-26. doi: 10.1016/j.dld.2012.07.001
    Read this paper